A66 / The University of Auckland, Inje University College of Medicine 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  A66 / The University of Auckland, Inje University College of Medicine
    Journal:  Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia. (Pubmed Central) -  Dec 24, 2022   
    Endometrial hyperplasia is caused by an excess of estrogen unopposed by progesterone...The primary treatment with LNG-IUD showed a 93% regression rate of endometrial hyperplasia, which was significantly higher than oral progestogens showing a 66% regression rate...While continuously receiving oral progestogens showed a 55% regression rate of endometrial hyperplasia, which was significantly lower than LNG-IUD treatment as an alternative option. Our data reports a significant response on regression of endometrial hyperplasia after LNG-IUD treatment in comparison with oral progestogen treatment.
  • ||||||||||  A66 / The University of Auckland, Inje University College of Medicine
    Journal:  Mesenteric and myocardial ischemia revealing lower limb sarcoma. (Pubmed Central) -  Dec 3, 2021   
    This may inform clinical and public health primary prevention efforts. Efforts are required for the systemic evaluation of various etiologies in patients with SMA embolism who require rapid diagnosis and intervention.